• norsk
    • English
  • English 
    • norsk
    • English
  • Login
View Item 
  •   Home
  • Øvrige samlinger
  • Publikasjoner fra CRIStin - NTNU
  • View Item
  •   Home
  • Øvrige samlinger
  • Publikasjoner fra CRIStin - NTNU
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Development and validation of a risk prediction model for esophageal squamous cell carcinoma using cohort studies

Wang, Qiaoli; Ness-Jensen, Eivind; Santoni, Giola; Xie, Shaohua; Lagergren, Jesper
Peer reviewed, Journal article
Accepted version
Thumbnail
View/Open
Wang (1.163Mb)
URI
https://hdl.handle.net/11250/2980846
Date
2021
Metadata
Show full item record
Collections
  • Institutt for samfunnsmedisin og sykepleie [2415]
  • Publikasjoner fra CRIStin - NTNU [26648]
Original version
American Journal of Gastroenterology. 2021, 116 (4), 683-691.   10.14309/ajg.0000000000001094
Abstract
INTRODUCTION:

Esophageal squamous cell carcinoma (ESCC) carries a poor prognosis, but earlier tumor detection would improve survival. We aimed to develop and externally validate a risk prediction model based on exposure to readily available risk factors to identify high-risk individuals of ESCC.

METHODS:

Competing risk regression modeling was used to develop a risk prediction model. Individuals' absolute risk of ESCC during follow-up was computed with the cumulative incidence function. We used prospectively collected data from the Nord-Trøndelag Health Study (HUNT) for model derivation and the UK Biobank cohort for validation. Candidate predictors were age, sex, tobacco smoking, alcohol consumption, body mass index (BMI), education, cohabitation, physical exercise, and employment. Model performance was validated internally and externally by evaluating model discrimination using the area under the receiver-operating characteristic curve (AUC) and model calibration.

RESULTS:

The developed risk prediction model included age, sex, smoking, alcohol, and BMI. The AUC for 5-year risk of ESCC was 0.76 (95% confidence interval [CI], 0.58–0.93) in the derivation cohort and 0.70 (95% CI, 0.64–0.75) in the validation cohort. The calibration showed close agreement between the predicted cumulative risk and observed probabilities of developing ESCC. Higher net benefit was observed when applying the risk prediction model than considering all participants as being at high risk, indicating good clinical usefulness. A web tool for risk calculation was developed: https://sites.google.com/view/escc-ugis-ki.

DISCUSSION:

This ESCC risk prediction model showed good discrimination and calibration and validated well in an independent cohort. This readily available model can help select high-risk individuals for preventive interventions.
Publisher
Lippincott, Williams & Wilkins
Journal
American Journal of Gastroenterology
Copyright
This is the authors' accepted manuscript to an article published by Wolters Kluwer Health, Inc.. Locked until 1/4-2022 due to copyright restrictions.

Contact Us | Send Feedback

Privacy policy
DSpace software copyright © 2002-2019  DuraSpace

Service from  Unit
 

 

Browse

ArchiveCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsDocument TypesJournalsThis CollectionBy Issue DateAuthorsTitlesSubjectsDocument TypesJournals

My Account

Login

Statistics

View Usage Statistics

Contact Us | Send Feedback

Privacy policy
DSpace software copyright © 2002-2019  DuraSpace

Service from  Unit